Keryx Biopharmaceuticals Inc (NASDAQ:KERX)

5.03
Delayed Data
As of Jun 20
 -0.16 / -3.08%
Today’s Change
3.92
Today|||52-Week Range
8.38
+8.17%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
AssetsCash74.3M200.3M111.8M93.5M
 
 
 
 
 
Short Term Investment Cash18.6M126.0M-88.5M-18.3M
 
 
 
 
 
Cash & Short Term Investments85.8M200.3M111.8M93.5M
 
 
 
 
 
 
ReceivablesReceivables882.0K4.3M5.2M8.1M
 
 
 
 
 
 
InventoriesInventories7.8M41.9M12.7M28.7M
 
 
 
 
 
 
Current AssetsPrepaid Expenses0.00----7.6M
 
 
Other Current Assets4.1M2.8M3.2M3.6M
 
 
 
 
 
Current Assets98.6M249.3M132.9M141.6M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross2.7M5.5M5.5M6.7M
 
 
 
 
 
Depreciation-1.2M-452.0K-1.2M-2.2M
 
 
 
 
 
Intangible Assets3.2M3.2M3.2M3.2M
 
 
 
 
 
Other Assets3.5M4.3M4.3M12.8M
 
 
 
 
 
Total Assets103.6M258.7M141.4M158.9M
 
 
 
 
 
 
LiabilitiesAccounts Payable24.1M21.3M2.2M6.5M
 
 
 
 
 
Accrued Expenses----10.8M31.1M
 
 
 
Other Current Liabilities414.0K50.8M11.1M31.4M
 
 
 
 
 
Other Liabilities29.3M77.6M21.6M45.4M
 
 
 
 
 
 
Total LiabilitiesLong Term Debt0.0090.8M125.0M125.0M
 
 
 
 
Deferred Taxes-700.0K-790.0K-870.0K-635.0K
 
 
 
 
 
Other Liabilities133.0K1.1M1.0M1.9M
 
 
 
 
 
Total Liabilities30.1M171.8M149.7M173.0M
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock0.000.000.000.00--
Common Equity73.5M86.9M-8.3M-14.1M
 
 
 
 
 
Total Shareholder Equity73.5M86.9M-8.3M-14.1M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding92.7M105.1M105.8M119.2M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.